Transcriptomics

Dataset Information

0

CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy


ABSTRACT: CD8+ T cells activated by cancer immunotherapy execute tumor clearance mainly by inducing cell death through perforin-granzyme- and Fas/Fas ligand-pathways. Ferroptosis is a form of cell death that differs from apoptosis and results from iron-dependent lipid peroxide accumulation. Although it was mechanistically illuminated in vitro, emerging evidence has shown that ferroptosis may be implicated in a variety of pathological scenarios. However, the involvement of ferroptosis in T cell immunity and cancer immunotherapy is unknown. Here, we find that immunotherapy-activated CD8+ T cells enhance ferroptosis-specific lipid peroxidation in tumor cells, and in turn, increased ferroptosis contributes to the anti-tumor efficacy of immunotherapy. Mechanistically, IFNg released from CD8+ T cells downregulates expression of SLC3A2 and SLC7A11, two subunits of glutamate-cystine antiporter system xc-, restrains tumor cell cystine uptake, and as a consequence, promotes tumor cell lipid peroxidation and ferroptosis. In preclinical models, depletion of cyst(e)ine by cyst(e)inase in combination with checkpoint blockade synergistically enhances T cell-mediated anti-tumor immunity and induces tumor cell ferroptosis. Thus, T cell-promoted tumor ferroptosis is a novel anti-tumor mechanism. Targeting tumor ferroptosis pathway constitutes a therapeutic approach in combination with checkpoint blockade.

ORGANISM(S): Homo sapiens

PROVIDER: GSE128392 | GEO | 2019/03/16

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2020-09-23 | GSE137946 | GEO
2023-08-30 | GSE237928 | GEO
2023-10-18 | E-MTAB-12241 | biostudies-arrayexpress
2020-08-25 | MSV000086009 | MassIVE
2024-07-16 | GSE272018 | GEO
2023-08-07 | GSE240106 | GEO
2021-03-31 | GSE171194 | GEO
2023-07-12 | GSE207741 | GEO
2023-12-31 | GSE247883 | GEO
2024-05-24 | GSE267823 | GEO